Evidence map›Paper›PMID 36202670›Full record

ReviewAcademic radiology2023

Multiparametric Quantitative Imaging Biomarkers for Phenotype Classification: A Framework for Development and Validation.

Jana G Delfino, Gene A Pennello, Huiman X Barnhart, Andrew J Buckler, Xiaofeng Wang, Erich P Huang, Dave L Raunig, Alexander R Guimaraes, Timothy J Hall, Nandita M deSouza and 1 more

Abstract readReview
In one paragraph

Review in Academic radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jana G DelfinoCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD. Electronic address: Jana.Delfino@fda.hhs.gov.
Gene A PennelloCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.
Huiman X BarnhartDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC.
Andrew J BucklerElucid Bioimaging, Inc, Boston, MA.
Xiaofeng WangDepartment of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Erich P HuangBiometric Research Program, Division of Cancer Treatment and Diagnosis - National Cancer Institute, National Institutes of Health, Bethesda, MD.
Dave L RaunigData Science Institute, Statistical and Quantitative Sciences, Takeda Pharmaceuticals America Inc, Lexington, MA.
Alexander R GuimaraesDepartment of Diagnostic Radiology, Oregon Health & Sciences University, Portland, OR.
Timothy J HallDepartment of Medical Physics, University of Wisconsin, Madison, WI.
Nandita M deSouzaDivision of Radiotherapy and Imaging, the Insitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom; European Imaging Biomarkers Alliance (EIBALL), European Society of Radiology (ESR), Vienna, Austria.
Nancy ObuchowskiDepartment of Quantitative Health Sciences, Lerner Research Institute Cleveland Clinic, Cleveland, OH.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

This manuscript is the third in a five-part series related to statistical assessment methodology for technical performance of multi-parametric quantitative imaging biomarkers (mp-QIBs). We outline approaches and statistical methodologies for developing and evaluating a phenotype classification model from a set of multiparametric QIBs. We then describe validation studies of the classifier for precision, diagnostic accuracy, and interchangeability with a comparator classifier. We follow with an end-to-end real-world example of development and validation of a classifier for atherosclerotic plaque phenotypes. We consider diagnostic accuracy and interchangeability to be clinically meaningful claims for a phenotype classification model informed by mp-QIB inputs, aiming to provide tools to demonstrate agreement between imaging-derived characteristics and clinically established phenotypes. Understanding that we are working in an evolving field, we close our manuscript with an acknowledgement of existing challenges and a discussion of where additional work is needed. In particular, we discuss the challenges involved with technical performance and analytical validation of mp-QIBs. We intend for this manuscript to further advance the robust and promising science of multiparametric biomarker development.

Indexed as

Diagnostic ImagingBiomarkersPhenotypeBiomarkersmulti-class classificationmultiparametric classificationmulti-parametric quantitative imaging biomarkers (mp-QIBs)phenotype classificationQIBA

Identifiers

PMID36202670
PMCPMC9825632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.